Striving to transform lives through medical science
EMD Serono, Inc. is a leader in the U.S. biopharmaceutical industry. We have more than 1,000 employees throughout the United States with fully integrated commercial, clinical, and research operations near Boston and headquarters in Rockland, Massachusetts.
EMD Serono has more than 30 trials in our global clinical pipeline, focused on developing innovative therapies for cancer and neurodegenerative diseases such as multiple sclerosis and Parkinson's disease.
This site contains information that is intended for US residents only. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada.